Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster Presentations at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting
October 24, 2022 08:30 ET
|
Motus GI Holdings, Inc.
Positive clinical data from feasibility and efficacy study of the Pure-Vu EVS conducted by Minneapolis VA Health Care System Overview of the results from an inpatient colonoscopy conducted at an ICU...
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods Embodied by the Pure-Vu® System
October 06, 2022 09:00 ET
|
Motus GI Holdings, Inc.
Patent provides additional intellectual property protection for methods to enable high-quality colonoscopy with no or minimal prepCompany believes reducing the burden associated with pre-procedural...
Motus GI Named a Sole Source Supplier with U.S. Department of Veteran Affairs
September 29, 2022 09:00 ET
|
Motus GI Holdings, Inc.
Multiple contracts with VA medical centers already executed for Pure-Vu EVS under the sole source supplier designation, with additional centers under evaluationApproximately 645,000 colonoscopies were...
Motus GI Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022 16:05 ET
|
Motus GI Holdings, Inc.
Pure-Vu EVS approved for use at 18 hospitals since launch in March 2022, resulting in highest quarterly revenue reported in the Company’s history Expansion of U.S. commercial footprint successfully...
Motus GI Regains Compliance with Nasdaq Minimum Bid Price Requirement
August 11, 2022 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that...
Motus GI Announces 1-FOR-20 Reverse Stock Split
July 25, 2022 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI to Release Second Quarter Results and Provide a Business Update on August 11
July 21, 2022 16:05 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022
May 24, 2022 16:05 ET
|
Motus GI Holdings, Inc.
– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation FORT LAUDERDALE, Fla., May 24, 2022 (GLOBE NEWSWIRE) -- Motus...
Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update
May 12, 2022 16:05 ET
|
Motus GI Holdings, Inc.
Pure-Vu EVS approved for use at 11 hospitals since product launch commenced in March 2022; with strong procedural volumes and significant positive feedback Expansion of US commercial footprint ahead...
Motus GI Announces Upcoming Presentation of Topline Data from the EU Study of the Pure-Vu System at Digestive Disease Week 2022
May 02, 2022 08:00 ET
|
Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve...